ALK-IN-29 (compound 4c) exhibits inhibitory effects on tyrosine protein kinases such as ALK, CDK2/CyclinE1, and FAK, with the strongest inhibition observed against ALK kinase, displaying a 40.63% inhibition rate at a concentration of 10 µM. ALK-IN-29 is applicable in cancer research.
Molekulargewicht:
457.58
Formel:
C29H32FN3O
Target-Kategorie:
CDK|||FAK
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
